| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000028920 |
| Receipt No. | R000033065 |
| Official scientific title of the study | Evaluation of peripheral retinal abnormalities in branch retinal vein occlusion - a relationship with the visual prognosis - |
| Date of disclosure of the study information | 2017/10/01 |
| Last modified on | 2017/08/31 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Evaluation of peripheral retinal
abnormalities in branch retinal vein occlusion - a relationship with the visual prognosis - |
|
| Title of the study (Brief title) | Peripheral retinal abnormalities and
visual prognosis in branch retinal vein occlusion |
|
| Region |
|
|
| Condition | ||
| Condition | Retinal Vein Occlusion | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To examine the relationship between
visual prognosis and the location of retinal abnormal findings detected by a wide-field fluorescein angiography as well as retinal photocoagulation (PHC) for the peripheral nonperfused area in patients with branch retinal vein occlusion. |
| Basic objectives2 | Others |
| Basic objectives -Others | Confirmatory
|
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | presence of microaneurysm, retinal
hyperpermeability, and neovascularization |
| Key secondary outcomes | best-corrected visual acuity, central
retinal thickness |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.RVO eyes with nonperfused areas
2.Japanese patients 3.Patients considered as eligible for study by the investigator |
|||
| Key exclusion criteria | 1.Patients whose images were too poor
quality to be analyzed, who had thick retinal hemorrhage or severe macular edema 2.Presence of other macular diseases 3.High myopia -6.0 diopter(D)or worse 4.Patients judged by the investigator to be ineligible for other reasons |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshio Hirano |
| Organization | Nagoya City University Graduate School of Medical Sciences
|
| Division name | Department of Ophthalmology and Visual Science |
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan |
| TEL | 052-853-8251 |
| yoshio.hirano@gmail.com | |
| Public contact | |
| Name of contact person | Yoshio Hirano |
| Organization | Nagoya City University Graduate School of Medical Sciences |
| Division name | Department of Ophthalmology and Visual Science |
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan |
| TEL | 052-853-8251 |
| Homepage URL | |
| yoshio.hirano@gmail.com | |
| Sponsor | |
| Institute | Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | The presence rates of microaneurysms,
vascular hyperpermeability, retinal neovascularization in the peripheral retina were significantly lower than in other areas. The presence of the retinal peripheral abnormalities or PHC for the retinal nonperfused area did not necessarily affect the visual prognosis and persistent macular edema. |
| Other related information | There was no association between the PHC
application and vitreous hemorrhage. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033065 |